Impact DX Factor V Leiden and Factor Ii Genotyping Test
System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations. 510(k) K132978, from Sequenom, Inc. (San Diego, CA). Product code PHJ, class 2.
As of Nov 19, 2026, K132978 is an FDA 510(k) held by Sequenom, Inc., substantially equivalent on Jun 13, 2014 after 263 days, with no recalls tied to it in FDA's recall database.
- Review time: 263 days
- Recalls: 0
The IMPACT Dx Factor V Leiden and Factor II Genotyping Test is a qualitative in vitro diagnostic device intended for use in the detection and genotyping of a single point mutation (G1691A, referred to as the Factor V Leiden mutation or FVL) of the Factor V gene, located on Chromosome 1q23, and a single point mutation (G20210A) of the prothrombin gene (referred to as Factor II or FII), located on…
- K033607K033607
- Factor Ii (Prothrombin) G20210A KitK033612 · Roche Diagnostics Corp. · Dec 18, 2003
- Lightcycler Instrument Version 1.2K033734 · Roche Diagnostics Corp. · Dec 17, 2003
- Infiniti SystemK060564 · AutoGenomics, Inc. · Feb 7, 2007
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 23, 2013
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7280
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files